LANTERN PHARMA INC's ticker is LTRN and the CUSIP is 51654W101. A total of 27 filers reported holding LANTERN PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $92,070 | -39.5% | 27,000 | 0.0% | 0.00% | – |
| Q2 2023 | $152,280 | +16.8% | 27,000 | 0.0% | 0.00% | – |
| Q1 2023 | $130,410 | +45.5% | 27,000 | +81.9% | 0.00% | – |
| Q4 2022 | $89,640 | +57.3% | 14,841 | +23.7% | 0.00% | – |
| Q3 2022 | $57,000 | -17.4% | 12,000 | -0.4% | 0.00% | – |
| Q2 2022 | $69,000 | -31.0% | 12,050 | -13.5% | 0.00% | – |
| Q1 2022 | $100,000 | -4.8% | 13,936 | +6.3% | 0.00% | – |
| Q4 2021 | $105,000 | +22.1% | 13,110 | +70.8% | 0.00% | – |
| Q3 2021 | $86,000 | -28.9% | 7,677 | -6.9% | 0.00% | – |
| Q2 2021 | $121,000 | +210.3% | 8,244 | +280.6% | 0.00% | – |
| Q1 2021 | $39,000 | +1850.0% | 2,166 | +1833.9% | 0.00% | – |
| Q3 2020 | $2,000 | -89.5% | 112 | -92.7% | 0.00% | – |
| Q2 2020 | $19,000 | – | 1,533 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SANDERS MORRIS HARRIS LLC | 365,930 | $1,721,000 | 0.42% |
| CM Management, LLC | 50,000 | $239,000 | 0.27% |
| WOLFF WIESE MAGANA LLC | 30,462 | $146,000 | 0.12% |
| Redmond Asset Management, LLC | 49,502 | $237,000 | 0.09% |
| CARLSON CAPITAL L P | 168,000 | $803,000 | 0.06% |
| NewEdge Advisors, LLC | 171,019 | $817,000 | 0.01% |
| Sigma Planning Corp | 17,500 | $84,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 3,984 | $19,000 | 0.00% |
| NORTHERN TRUST CORP | 12,629 | $60,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |